Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Express Scripts
Moodys
QuintilesIMS
Harvard Business School
Federal Trade Commission
Daiichi Sankyo
Mallinckrodt

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202984

« Back to Dashboard

NDA 202984 describes CLONIDINE HYDROCHLORIDE , which is a drug marketed by Anchen Pharms and Par Pharm and is included in four NDAs. It is available from sixty-four suppliers. Additional details are available on the CLONIDINE HYDROCHLORIDE profile page.

The generic ingredient in CLONIDINE HYDROCHLORIDE is chlorthalidone; clonidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.
Summary for 202984
Tradename:CLONIDINE HYDROCHLORIDE
Applicant:Anchen Pharms
Ingredient:clonidine hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202984
Mechanism of ActionAdrenergic alpha2-Agonists
Suppliers and Packaging for NDA: 202984
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 202984 ANDA Par Pharmaceutical, Inc. 10370-257 N 10370-257-02
CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 202984 ANDA Par Pharmaceutical, Inc. 10370-257 N 10370-257-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength0.1MG
Approval Date:Sep 30, 2013TE:AB1RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength0.2MG
Approval Date:Sep 30, 2013TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Baxter
Healthtrust
Argus Health
UBS
Boehringer Ingelheim
US Army
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.